BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9348248)

  • 1. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis.
    Marthin T; Liedgren S; Hammar M
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):728-32. PubMed ID: 9348248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplacental needle passage in early amniocentesis and pregnancy loss.
    Bravo RR; Shulman LP; Phillips OP; Grevengood C; Martens PR
    Obstet Gynecol; 1995 Sep; 86(3):437-40. PubMed ID: 7651657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic mid trimester amniocentesis: how safe?
    Seeds JW
    Am J Obstet Gynecol; 2004 Aug; 191(2):607-15. PubMed ID: 15343248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonic placental localization in relation to spontaneous abortion after mid-trimester amniocentesis.
    Hill JA; Reindollar RH; McDonough PG
    Prenat Diagn; 1982 Oct; 2(4):289-95. PubMed ID: 7156025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic amniocentesis: impact of placental position upon the risk of pregnancy loss.
    Crane JP; Kopta MM
    Am J Obstet Gynecol; 1984 Dec; 150(7):813-6. PubMed ID: 6391172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome following second-trimester amniocentesis: a case-control study.
    Müngen E; Tütüncü L; Muhcu M; Yergök YZ
    Am J Perinatol; 2006 Jan; 23(1):25-30. PubMed ID: 16450269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pregnancy outcomes after second trimester amniocentesis between procedures performed by experts and non-experts.
    Wisetmongkolchai T; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T; Jatavan P
    J Perinat Med; 2021 May; 49(4):474-479. PubMed ID: 33554581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcome following mid-trimester amniocentesis.
    Corrado F; Cannata ML; La Galia T; Magliarditi M; Imbruglia L; D'anna R; Carlo Stella N
    J Obstet Gynaecol; 2012 Feb; 32(2):117-9. PubMed ID: 22296417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical factors in early amniocentesis predict adverse outcome. Results of the Canadian Early (EA) versus Mid-trimester (MA) Amniocentesis Trial.
    Johnson JM; Wilson RD; Singer J; Winsor E; Harman C; Armson BA; Benzie R; Dansereau J; Ho MF; Mohide P; Natale R; Okun N
    Prenat Diagn; 1999 Aug; 19(8):732-8. PubMed ID: 10451517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal loss rate after second trimester amniocentesis at different gestational age.
    Saltvedt S; Almström H
    Acta Obstet Gynecol Scand; 1999 Jan; 78(1):10-4. PubMed ID: 9926885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedure-related fetal losses in transplacental versus nontransplacental genetic amniocentesis.
    Bombard AT; Powers JF; Carter S; Schwartz A; Nitowsky HM
    Am J Obstet Gynecol; 1995 Mar; 172(3):868-72. PubMed ID: 7892877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester amniocentesis vs. chorionic villus sampling for prenatal diagnosis in multiple gestations.
    Antsaklis A; Souka AP; Daskalakis G; Kavalakis Y; Michalas S
    Ultrasound Obstet Gynecol; 2002 Nov; 20(5):476-81. PubMed ID: 12423485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplacental amniocentesis: is it really a higher-risk procedure?
    Giorlandino C; Mobili L; Bilancioni E; D'Alessio P; Carcioppolo O; Gentili P; Vizzone A
    Prenat Diagn; 1994 Sep; 14(9):803-6. PubMed ID: 7845887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of midtrimester amniocentesis; assessment in 3000 pregnancies.
    Leschot NJ; Verjaal M; Treffers PE
    Br J Obstet Gynaecol; 1985 Aug; 92(8):804-7. PubMed ID: 4027202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 2136 genetic amniocenteses: experience of a single physician.
    Hanson FW; Tennant FR; Zorn EM; Samuels S
    Am J Obstet Gynecol; 1985 Jun; 152(4):436-43. PubMed ID: 4014336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of second-trimester amniocentesis in twin gestations: a case-control study.
    Ghidini A; Lynch L; Hicks C; Alvarez M; Lockwood CJ
    Am J Obstet Gynecol; 1993 Oct; 169(4):1013-6. PubMed ID: 8238111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal loss associated with second trimester amniocentesis.
    Pitukkijronnakorn S; Promsonthi P; Panburana P; Udomsubpayakul U; Chittacharoen A
    Arch Gynecol Obstet; 2011 Oct; 284(4):793-7. PubMed ID: 21052703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group.
    Lancet; 1998 Jan; 351(9098):242-7. PubMed ID: 9457093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy loss rates after midtrimester amniocentesis.
    Eddleman KA; Malone FD; Sullivan L; Dukes K; Berkowitz RL; Kharbutli Y; Porter TF; Luthy DA; Comstock CH; Saade GR; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Obstet Gynecol; 2006 Nov; 108(5):1067-72. PubMed ID: 17077226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.